Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.
Hess
K R
KR
Abbruzzese
J L
JL
D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D061965:Matrix Metalloproteinase Inhibitors; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D016032:Randomized Controlled Trials as Topic / Q000379:methods
D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D061965:Matrix Metalloproteinase Inhibitors; C100342:marimastat